ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

NIAID, Vaccine Center Begin Phase I Trial Of AIDS Vaccine.

October 12, 2001

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

House, Senate Agree On $1.91 Billion NCI Appropriations

September 30, 1994